Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2004
12/08/2004CN1552343A Sodium alginate diester drops and their preparing method
12/08/2004CN1552342A Medicine for preventing gynaecological disease
12/08/2004CN1552341A Medicine for preventing diabets mellitus
12/08/2004CN1552340A Medicine for preventing nephroma
12/08/2004CN1552339A Methyleritrocina injection
12/08/2004CN1552338A Medicine for preventing cardiovascular disease
12/08/2004CN1552337A Medicine for preventing cerebrovascular disease
12/08/2004CN1552336A Medicine for preventing prostatic disorders
12/08/2004CN1552335A Ginseng and ophiopogon saponin drops and their preparing method
12/08/2004CN1552334A Medicinal composition for treating cardiovascular disease
12/08/2004CN1552333A Medicine for preventing depression
12/08/2004CN1552332A Enteric sotuble preparation of Adefuwei double-graded valeryl oxomethyl ester
12/08/2004CN1552331A Improvement of chronic mild stress BALB/C mouse depression by compound 7-carbonyl epiandrosterone
12/08/2004CN1552330A Paint for treating benign prostate hyperplasia and its use
12/08/2004CN1552329A Powder injection of cefpiramide
12/08/2004CN1552328A Use of phenoxthine compounds in preparing medicnies for inhibiting cancers and promoting radio-sensitive medicines
12/08/2004CN1552327A Oral ofloxacin control-sustained releasing medicinal composition
12/08/2004CN1552326A Method for stabilizing intravenous injection of azasejoin
12/08/2004CN1552325A Doxofyline osmotic pump controlled releasing preparation and its production
12/08/2004CN1552324A Medicinal composition for stabilizing delotadine in preparation
12/08/2004CN1552323A Monolayer osmotic pump controlled releasing tablets of nimodipine
12/08/2004CN1552322A Pharmaceutical compositions of tizoxanide and nitazoxanide
12/08/2004CN1552321A Use of Abidol in preparing medicines for treating and preventing SARS virus
12/08/2004CN1552320A Andrographolide compound solubilizing preparing method and medicinal preparation
12/08/2004CN1552319A Bilobanone drops
12/08/2004CN1552318A Hawthorn leave flavone capsules and their preparing method
12/08/2004CN1552317A Preparation of Xindakang
12/08/2004CN1552316A Houttuynia cordata sodium cyclodextrin dressing material, preparation and preparing method thereof
12/08/2004CN1552315A 治疗组合物 The therapeutic composition
12/08/2004CN1552314A Antibacterial medicinal composition
12/08/2004CN1552311A Oral dissolved fenofibrate tablets
12/08/2004CN1552310A Preparation of powder agglomerates
12/08/2004CN1552309A Method for promoting solid cilostazol to dissolve out
12/08/2004CN1179047C Method for introducing substances into cells and use of said method
12/08/2004CN1179046C Erythromycins and its preparation method, use and compositions
12/08/2004CN1179026C Fat compositions
12/08/2004CN1178955C Modified TNF alpha molecules and DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
12/08/2004CN1178951C Noval erythromycin derivatives and its preparing method and its use thereof as drugs
12/08/2004CN1178941C CRF receptor antagonists and method relating thereof
12/08/2004CN1178940C Selective antagonists of A28 adenosine receptors
12/08/2004CN1178939C Non-nucleoside reverse transcriptase inhibitors
12/08/2004CN1178938C 1,2-annelated quinoline derivatives
12/08/2004CN1178936C Sulfonyl-pyrrolidine derivatives
12/08/2004CN1178935C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
12/08/2004CN1178934C Benzofurane derivatives
12/08/2004CN1178932C Amide derivatives
12/08/2004CN1178931C Substituted pyrazole compounds
12/08/2004CN1178927C Histamine H3 receptor ligands
12/08/2004CN1178923C 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists
12/08/2004CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
12/08/2004CN1178921C Preparation of sulfonamides
12/08/2004CN1178917C N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
12/08/2004CN1178915C Alkynyl containing hydroxamic acid derivatives and its preparation and its use as matrix metalloproteinase (MMP) inhibitors/TNF-alpha converting enzyme (TACE) inhibitors
12/08/2004CN1178914C 4-benzyl-1-[2-(4-hydroxy-phenoxy)-ethyl]-piperidine-3,4-diol
12/08/2004CN1178913C Aromatic heterocycle compounds having HIV integrase inhibiting activities
12/08/2004CN1178912C Small molecule inhibitors of rotamase enzyme activity
12/08/2004CN1178911C Pyrrolidine and piperidine derivatives and their use for treatment of neurodegenerative disorders
12/08/2004CN1178907C 3-(fatty acid)-1,2 gluceride disulfate and its preparing method and application
12/08/2004CN1178906C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/08/2004CN1178905C Novel peptide derivative
12/08/2004CN1178901C New-cyclic alpha-amino-gamma hydroxy amide compound and its preparing method and medicinal composition containing said compound
12/08/2004CN1178900C Anti-tumour agents
12/08/2004CN1178895C Naprosyn precusor and its synthesis method and its application
12/08/2004CN1178890C Method for extracting hypericin from hypericum perforatum
12/08/2004CN1178889C Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same
12/08/2004CN1178699C Pharmaceutical compositions containing compounds with activity for enhancement of absorption of active ingredients
12/08/2004CN1178696C Preparation for treatment of metabolic syndrome containing human growth hormone in combination with cortisol synthesis inhibitor
12/08/2004CN1178694C Use of IL-12 and IFN-'alpha' for treatment of infectiong diseases
12/08/2004CN1178688C Health-care food for resisting fatigue
12/08/2004CN1178687C Compound seabuckthorn fruit oil suppository
12/08/2004CN1178680C Medicine of treating dermatosis for external use
12/08/2004CN1178668C Use of Chinese angelica polysaccharide in oral colon orientation releasing pro-drug
12/08/2004CN1178667C Glycosaminoglycans having average molecular weight equal to 2400 D suitable for treatment of senile dementia
12/08/2004CN1178666C Gypenoside drip pill, and preparing process thereof
12/08/2004CN1178665C Water soluble prodrugs of azole compounds
12/08/2004CN1178664C Remedy for axillary osmidrosis containing adrenocorticosteriodal preparation
12/08/2004CN1178663C Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance
12/08/2004CN1178662C Oral 2-methyl-thieno-benzodiazepine formulation
12/08/2004CN1178661C Use of brinzolamide to prevent visual field loss
12/08/2004CN1178660C Antiviral combinations of lamivudine and adefovir
12/08/2004CN1178659C Madicament formulation with controlled release of active agent
12/08/2004CN1178658C Process for synthesizing Cox-2 inhibitors
12/08/2004CN1178657C Treatment and prophylaxis of pancreatitis
12/08/2004CN1178656C Pharmaceutical composition
12/08/2004CN1178655C Water-miscible pharmaceutical compositions of paclitaxel
12/08/2004CN1178654C Chloromycetin kibe ointment
12/08/2004CN1178653C Drug composition
12/08/2004CN1178652C Mizoribine tablet with improved colour
12/08/2004CN1178651C Lyophilized thioxanthenone anti-tumor agents
12/08/2004CN1178650C Multiple unit controlled non-independent release pharmaceutical preparations and method for preparing same
12/08/2004CN1178649C Copmound zinc undecylenate ointment for treating beriberi
12/08/2004CN1178648C Use of H+, K+-ATPase inhibitors in preparing oral medicine for enhancing inhibition of gastric acid secretion
12/08/2004CN1178642C Oral care compositions
12/08/2004CN1178639C Washing cosmetic composition and use thereof
12/08/2004CN1178592C Drinks and foods capable of eliminating helicobacter pylori
12/07/2004US6828473 Transgenic mammal for use in the treatment of cancer and inflammatory disease
12/07/2004US6828462 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists
12/07/2004US6828458 Topical antiandrogen for hair loss and other hyperandrogenic conditions
12/07/2004US6828456 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
12/07/2004US6828451 Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry